Sullivan Christopher Ryan bought AVTX
September 10, 2026 · Form 4 insider transaction
Sullivan Christopher Ryan bought 10,185 shares of Avalo Therapeutics, Inc. at $8.04 per share, a transaction worth $81.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,185
Price
$8.04
Total value
$81.9K
InsiderSullivan Christopher Ryan
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 10, 2026
Filing dateSeptember 11, 2026
Shares owned after50,085
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.